Loading clinical trials...
Loading clinical trials...
Efficacy, Safety and Immunogenicity of GVGH Shigella Sonnei Vaccine (1790GAHB) in a Human Challenge Study of Healthy Non-immune Adults
Conditions
Interventions
S.sonnei vaccine
Placebo
+1 more
Locations
1
United States
GSK Investigational Site
Cincinnati, Ohio, United States
Start Date
August 29, 2018
Primary Completion Date
May 8, 2019
Completion Date
November 11, 2019
Last Updated
July 28, 2020
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions